Search results

Learn about the NICE Technology Appraisal and Highly Specialised Technologies appeals process, including how decisions are made, the criteria for appeals, and the role of the appeal panel in ensuring fair and transparent evaluations of health technologies.

NICE fees for technology appraisals and highly specialised technologies

NICE's technology appraisal guidance makes recommendations on the use of new and existing medicines and other treatments within the NHS.

Clarification on demonstrating patient access to medicines and treatments recommended by NICE Technology Appraisal (TA) or Highly Specialised Technologies (HST) guidance.

NICE has a key role in UK licensing and the evaluation of and access to new and innovative products for the health system.

Home What NICE does Our guidance About technology appraisal guidance {"@context":"http://schema.org","@type":"BreadcrumbList","itemListElement":

Data on the cancer recommendations made by our technology appraisal programme. Includes information on the number of positive recommendations we've made.

Data on the recommendations made by our technology appraisal programme. Includes information on the number of positive recommendations we've made.

Home What NICE does Our guidance About technology appraisal guidance Our methods and processes (health technology evaluation manual)...

All the templates and supporting documents you need to make a technology appraisals submission with NICE.

Engage at the optimal time for your technology appraisal, to achieve NICE guidance at the same time as marketing authorisation.

Evidence-based recommendations on enzyme-linked immunosorbent assay (ELISA) tests for therapeutic monitoring of tumour necrosis factor (TNF)-alpha inhibitors in rheumatoid arthritis. The tests are Promonitor, IDKmonitor, LISA-tracker, RIDASCREEN, MabTrack, and those used by Sanquin Diagnostic Services.

Result type

HealthTech guidance

Published

10 July 2019

Evidence-based recommendations on therapeutic monitoring of tumour necrosis factor (TNF)-alpha inhibitors (LISA-TRACKER, IDKmonitor and Promonitor ELISA kits) in people with Crohn’s disease.

Result type

HealthTech guidance

Published

17 February 2016

Evidence-based recommendations on the My5-FU assay for measuring levels of 5-flurouracil (5-FU) in patients having chemotherapy, to help guide changes to the dose of 5-FU.

Result type

HealthTech guidance

Published

10 December 2014

Evidence-based recommendations on viscoelastometric point-of-care testing devices (the ROTEM, TEG and Sonoclot systems).

Result type

HealthTech guidance

Published

20 August 2014